Although patients with HCC generally show lower serum ALB levels that are associated with poor survivals3, TM4SF5-mediated patients with HCC (that is, patients with HCC with TM4SF5 increases over nontumor samples) showed increased ALB mRNA and protein expression in the liver (Fig. 6a,b). This evidence concerns the gene ALB and hepatocellular carcinoma.